The effect of FTY720 in the Theiler's virus model of multiple sclerosis

Cohen, 2010, Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis, N Engl J Med, 362, 402, 10.1056/NEJMoa0907839 Kappos, 2010, A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis, N Engl J Med, 362, 387, 10.1056/NEJMoa0909494 Brinkmann, 2002, The immune modulator FTY720 targets sphingosine 1-phosphate receptors, J Biol Chem, 277, 21453, 10.1074/jbc.C200176200 Pham, 2008, S1P1 receptor signaling overrides retention mediated by G alpha i-coupled receptors to promote T cell egress, Immunity, 28, 122, 10.1016/j.immuni.2007.11.017 Mehling, 2008, FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis, Neurology, 71, 1261, 10.1212/01.wnl.0000327609.57688.ea Foster, 2007, Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis, J Pharmacol Exp Ther, 323, 469, 10.1124/jpet.107.127183 Brinkmann, 2010, Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis, Nat Rev Drug Discov, 9, 1, 10.1038/nrd3248 Miron, 2008, Cyclical and dose-dependent responses of adult human mature oligodendrocytes to fingolimod, Am J Pathol, 173, 1143, 10.2353/ajpath.2008.080478 Dal Canto, 1977, Multiple sclerosis. Animal model: Theiler's virus infection in mice, Am J Pathol, 88, 497 McGavern, 1999, Quantitative assessment of neurologic deficits in a chronic progressive murine model of CNS demyelination, Exp Neurol, 158, 171, 10.1006/exnr.1999.7082 Zoecklein, 2003, Direct comparison of demyelinating disease induced by the Daniel's strain and BeAn strain of Theiler's murine encephalomyelitis virus, Brain Pathol, 13, 291, 10.1111/j.1750-3639.2003.tb00029.x Pinschewer, 2000, FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory, J Immunol, 164, 5761, 10.4049/jimmunol.164.11.5761 Webb, 2004, Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice, J Neuroimmunol, 153, 108, 10.1016/j.jneuroim.2004.04.015 Kataoka, 2005, FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration, Cell Mol Immunol, 2, 439 Trottier, 2001, High numbers of viral RNA copies in the central nervous system of mice during persistent infection with Theiler's virus, J Virol, 75, 7420, 10.1128/JVI.75.16.7420-7428.2001 Li, 2006, Intrathecal antibody production in a mouse model of Lyme neuroborreliosis, J Neuroimmunol, 173, 56, 10.1016/j.jneuroim.2005.11.019 Pachner, 2007, Antibody-secreting cells in the central nervous system in an animal model of MS: phenotype, association with disability, and in vitro production of antibody, J Neuroimmunol, 190, 112, 10.1016/j.jneuroim.2007.09.001 Pachner, 2007, Intrathecal antibody production in an animal model of multiple sclerosis, J Neuroimmunol, 185, 57, 10.1016/j.jneuroim.2007.01.017 Tschen, 2002, Recruitment kinetics and composition of antibody-secreting cells within the central nervous system following viral encephalomyelitis, J Immunol, 168, 2922, 10.4049/jimmunol.168.6.2922 Lipton, 1978, Central nervous system immunity in mice infected with theiler's virus. I. Local neutralizing antibody response, J Infect Dis, 137, 145, 10.1093/infdis/137.2.145 Pachner, 2003, An improved ELISA for screening for neutralizing anti-IFN-beta antibodies in MS patients, Neurology, 61, 1444, 10.1212/01.WNL.0000094198.37489.11 Narayan, 2005, The nervous system as ectopic germinal center: CXCL13 and IgG in lyme neuroborreliosis, Ann Neurol, 57, 813, 10.1002/ana.20486 Kurtz, 1995, Protection of SJL/J mice from demyelinating disease mediated by Theiler's murine encephalomyelitis virus, Microb Pathog, 18, 11, 10.1016/S0882-4010(05)80009-9 Trottier, 2004, Transition from acute to persistent Theiler's virus infection requires active viral replication that drives proinflammatory cytokine expression and chronic demyelinating disease, J Virol, 78, 12480, 10.1128/JVI.78.22.12480-12488.2004 Mehling, 2010, Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis, Neurology, 75, 403, 10.1212/WNL.0b013e3181ebdd64 Kim, 2001, Pathogenesis of virus-induced immune-mediated demyelination, Immunol Res, 24, 121, 10.1385/IR:24:2:121 Rodriguez, 2007, Effectors of demyelination and remyelination in the CNS: implications for multiple sclerosis, Brain Pathol, 17, 219, 10.1111/j.1750-3639.2007.00065.x Lipton, 1976, Theiler's virus-induced demyelination: prevention by immunosuppression, Science, 192, 62, 10.1126/science.176726 Tan, 2010, Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis, Lancet Neurol, 9, 425, 10.1016/S1474-4422(10)70040-5 Foster, 2009, FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood–brain-barrier damage, Brain Pathol, 19, 254, 10.1111/j.1750-3639.2008.00182.x Balatoni, 2007, FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis, Brain Res Bull, 74, 307, 10.1016/j.brainresbull.2007.06.023 Fujino, 2003, Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment, J Pharmacol Exp Ther, 305, 70, 10.1124/jpet.102.045658 Meinl, 2006, B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation, Ann Neurol, 59, 880, 10.1002/ana.20890 Pachner, 2011, Plasma cells in the central nervous system in the Theiler's virus model of multiple sclerosis, J Neuroimmunol, 232, 35, 10.1016/j.jneuroim.2010.09.026 Fairfax, 2008, Plasma cell development: from B-cell subsets to long-term survival niches, Semin Immunol, 20, 49, 10.1016/j.smim.2007.12.002 McMahon, 2005, Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis, Nat Med, 11, 335, 10.1038/nm1202 Matsushita, 2008, Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression, J Clin Invest, 118, 3420 Lipton, 1977, Contrasting effects of immunosuppression on Theiler's virus infection in mice, Infect Immun, 15, 903, 10.1128/IAI.15.3.903-909.1977